Auditory P300 abnormalities and leukocyte activation in HIV infection

Area of Science:

• Neuroscience
• Immunology
• Infectious Diseases

Background:

• Human immunodeficiency virus (HIV) infection can lead to neurological complications, termed HIV-associated neuropathology.
• Early detection of neurological dysfunction is crucial for timely intervention and management in HIV-infected individuals.
• Current screening methods may not identify subclinical neurological involvement effectively.

Purpose of the Study:

• To assess the utility of P300 event-related potential testing as a screening tool for early HIV-associated neuropathology.
• To investigate the correlation between P300 latency abnormalities and clinical/biochemical markers in HIV infection.

Main Methods:

• P300 event-related potentials were measured in 26 HIV-infected men and 15 healthy controls.
• Participants included individuals with no neurological symptoms, peripheral neuropathy, and AIDS-associated dementia.
• P300 latencies were analyzed and compared with CD4 T-cell count, serum quinolinic acid, p24 antigen, and monocyte activation.

Main Results:

• Thirty percent of HIV-infected individuals without overt neurological symptoms exhibited delayed or undetectable P300 latencies.
• Abnormal P300 latencies did not correlate with CD4 counts, viral markers, or monocyte activation.
• Early HIV-seropositive individuals (< or = 1 year) showed abnormal P300 latencies, suggesting early neurological dysfunction.

Conclusions:

• P300 testing demonstrates potential as a sensitive, quantitative, and rapid screening method for early neurological involvement in HIV infection.
• While P300 responses do not predict imminent dementia, they may identify subclinical neuropathology.
• Further longitudinal studies are required to establish the predictive value of P300 latencies for AIDS-related dementia.